• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Post Operative Wound Infection (2446)
Event Type  Injury  
Manufacturer Narrative
Literature citation: bingyi tan, haiyan wang, jun dong, zenong yuan, dachuan wang, feng wang." comparison of rhbmp-2 versus autogenous iliac crest bone graft for 2 level anterior cervical discectomy and fusion for cervical spondylotic myelopathy" a3.Gender: 42 males and 31 females neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
 
Event Description
It was reported in an abstract, between (b)(6) 2007 and (b)(6) 2011, medical records of a total of 83 consecutive patients, with mean age (b)(6), diagnosed with csm and who underwent a 2-level (2 or more levels) acdf with iliac crest bone graft plus rhbmp-2/acs (0.9 mg of rhbmp-2 per level) along with plate fixation in our hospital were retrospectively reviewed.All patients were placed in the supine position on the operating room table, and underwent acdf with autogenously icbg which mainly consisted of complete discectomy and burring down of the uncinated processes.Rhbmp-2 was reconstituted according to the manufacturer's instructions and combined with local autograft.The same screw rod implant system was used in all subjects.In the rhbmp-2 group, 4 patients had deep wound infection.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5955431
MDR Text Key54878422
Report Number1030489-2016-02568
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/23/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/23/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
-
-